Featured Publications

Leveraging a deep bench of expertise and foundational experience in DNA medicine development, we’re driving research that has the potential to transform treatment paradigms and improve patients’ lives.

Other Development Candidates

Title Disease Target Product
DNA-encoded bispecific T cell engagers and antibodies present long-term antitumor activity
JCI Insight — April 2019
Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape
Molecular Therapy - Oncolytics — March 2023
Glioblastoma Multiforme EGFRvIII-DBTE
Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo
Frontiers in Immunology — February 2023
Melanoma Antibody-cytokine chimera TA99-HL2-KOA1 with DLnano-vaccine